• info@esgwise.org

Why Short-Term Profits Are Corporate Junk Food

Short term profits are certainly tasty. Increasing quarterly earnings are celebrated with abundant praise from Wall Street analysts, the press and shareholders reveling in rising stock prices. But this focus on immediate financial gains often comes at the expense of long-term fiscal health. It’s much like eating junk food: it may feel good for a moment, but it’s not good…

Why Short-Term Profits Are Corporate Junk Food

Short term profits are certainly tasty. Increasing quarterly earnings are celebrated with abundant praise from Wall Street analysts, the press and shareholders reveling in rising stock prices. But this focus on immediate financial gains often comes at the expense of long-term fiscal health. It’s much like eating junk food: it may feel good for a moment, but it’s not good…

Why Short-Term Profits Are Corporate Junk Food

Short term profits are certainly tasty. Increasing quarterly earnings are celebrated with abundant praise from Wall Street analysts, the press and shareholders reveling in rising stock prices. But this focus on immediate financial gains often comes at the expense of long-term fiscal health. It’s much like eating junk food: it may feel good for a moment, but it’s not good…

Why Short-Term Profits Are Corporate Junk Food

Short term profits are certainly tasty. Increasing quarterly earnings are celebrated with abundant praise from Wall Street analysts, the press and shareholders reveling in rising stock prices. But this focus on immediate financial gains often comes at the expense of long-term fiscal health. It’s much like eating junk food: it may feel good for a moment, but it’s not good…

Why Short-Term Profits Are Corporate Junk Food

Short term profits are certainly tasty. Increasing quarterly earnings are celebrated with abundant praise from Wall Street analysts, the press and shareholders reveling in rising stock prices. But this focus on immediate financial gains often comes at the expense of long-term fiscal health. It’s much like eating junk food: it may feel good for a moment, but it’s not good…

Why Short-Term Profits Are Corporate Junk Food

Short term profits are certainly tasty. Increasing quarterly earnings are celebrated with abundant praise from Wall Street analysts, the press and shareholders reveling in rising stock prices. But this focus on immediate financial gains often comes at the expense of long-term fiscal health. It’s much like eating junk food: it may feel good for a moment, but it’s not good…

Why Short-Term Profits Are Corporate Junk Food

Short term profits are certainly tasty. Increasing quarterly earnings are celebrated with abundant praise from Wall Street analysts, the press and shareholders reveling in rising stock prices. But this focus on immediate financial gains often comes at the expense of long-term fiscal health. It’s much like eating junk food: it may feel good for a moment, but it’s not good…

Why Short-Term Profits Are Corporate Junk Food

Short term profits are certainly tasty. Increasing quarterly earnings are celebrated with abundant praise from Wall Street analysts, the press and shareholders reveling in rising stock prices. But this focus on immediate financial gains often comes at the expense of long-term fiscal health. It’s much like eating junk food: it may feel good for a moment, but it’s not good…

Why Short-Term Profits Are Corporate Junk Food

Short term profits are certainly tasty. Increasing quarterly earnings are celebrated with abundant praise from Wall Street analysts, the press and shareholders reveling in rising stock prices. But this focus on immediate financial gains often comes at the expense of long-term fiscal health. It’s much like eating junk food: it may feel good for a moment, but it’s not good…

Pharma Supply Chain Decarbonization Consortium Signs 10-Year Clean Energy Deals for Haleon, GSK, Thermo  Fisher, Gilead

Pharma Supply Chain Decarbonization Consortium Signs 10-Year Clean Energy Deals for Haleon, GSK, Thermo Fisher, Gilead

Pharmaceutical supply chain decarbonization initiative Energize announced today a new aggregate power purchase agreement (PPA) with renewable energy developer X-ELIO, providing healthcare companies Haleon and GSK, Gilead Sciences and Thermo Fisher Scientific with 245 GWh of renewable energy annually over 10 years. Managed by energy and automation digital solutions provider Schneider Electric together with the Pharmaceutical Supply Chain Initiative, the…